Search details
1.
NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine.
J Neurosci
; 43(6): 1038-1050, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-36596696
2.
Computer-assisted semi-rational design enhanced the enzymatic activity and protein stability of Proteinase K in calcium-free conditions.
Biochem Biophys Res Commun
; 721: 150109, 2024 Aug 20.
Article
in English
| MEDLINE | ID: mdl-38762932
3.
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine.
J Clin Psychopharmacol
; 43(2): 89-96, 2023.
Article
in English
| MEDLINE | ID: mdl-36821406
4.
Ketamine modulates fronto-striatal circuitry in depressed and healthy individuals.
Mol Psychiatry
; 26(7): 3292-3301, 2021 07.
Article
in English
| MEDLINE | ID: mdl-32929215
5.
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response.
Mol Psychiatry
; 26(8): 4085-4095, 2021 08.
Article
in English
| MEDLINE | ID: mdl-31732715
6.
NMDAR inhibition-independent antidepressant actions of ketamine metabolites.
Nature
; 533(7604): 481-6, 2016 05 26.
Article
in English
| MEDLINE | ID: mdl-27144355
7.
Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function.
Proc Natl Acad Sci U S A
; 116(11): 5160-5169, 2019 03 12.
Article
in English
| MEDLINE | ID: mdl-30796190
8.
Bag-1 mediates glucocorticoid receptor trafficking to mitochondria after corticosterone stimulation: Potential role in regulating affective resilience.
J Neurochem
; 158(2): 358-372, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33025573
9.
A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression.
Int J Neuropsychopharmacol
; 23(7): 417-425, 2020 07 29.
Article
in English
| MEDLINE | ID: mdl-32236521
10.
Zanos et al. reply.
Nature
; 546(7659): E4-E5, 2017 06 21.
Article
in English
| MEDLINE | ID: mdl-28640272
11.
KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia.
Mol Psychiatry
; 21(11): 1517-1526, 2016 11.
Article
in English
| MEDLINE | ID: mdl-26857598
12.
Cerebrospinal fluid monocyte chemoattractant protein-1 in alcoholics: support for a neuroinflammatory model of chronic alcoholism.
Alcohol Clin Exp Res
; 38(5): 1301-6, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24689518
13.
Biomarkers in mood disorders research: developing new and improved therapeutics.
Rev Psiquiatr Clin
; 41(5): 131-134, 2014.
Article
in English
| MEDLINE | ID: mdl-26082563
14.
Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.
Int J Neuropsychopharmacol
; 16(2): 301-11, 2013 Mar.
Article
in English
| MEDLINE | ID: mdl-22676966
15.
Exome-wide association study of treatment-resistant depression suggests novel treatment targets.
Sci Rep
; 13(1): 12467, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-37528149
16.
Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion.
iScience
; 26(12): 108527, 2023 Dec 15.
Article
in English
| MEDLINE | ID: mdl-38162029
17.
Orientation and cellular distribution of membrane-bound catechol-O-methyltransferase in cortical neurons: implications for drug development.
J Biol Chem
; 286(40): 34752-60, 2011 Oct 07.
Article
in English
| MEDLINE | ID: mdl-21846718
18.
Dynamic regulation of mitochondrial function by glucocorticoids.
Proc Natl Acad Sci U S A
; 106(9): 3543-8, 2009 Mar 03.
Article
in English
| MEDLINE | ID: mdl-19202080
19.
Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration.
Transl Psychiatry
; 12(1): 179, 2022 05 02.
Article
in English
| MEDLINE | ID: mdl-35501309
20.
Experimenters' sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor.
Nat Neurosci
; 25(9): 1191-1200, 2022 09.
Article
in English
| MEDLINE | ID: mdl-36042309